Avoidance of Endophthalmitis After Intravitreal Injection
By: Nathan C. Steinle, MD; Aimee V. Chappelow, MD; Rishi P. Singh, M.D.
Does Microincisional Vitrectomy Surgery Increase the Risk for Endophthalmitis?
By: Surajit Saha, AB; Bryan Propes, MD; Katherine A. Fallano, BA; Diana V. Do, MD
Brachytherapy for Uveal Melanoma: New Developments and Controversies
By: Amy C. Schefler, MD; Timothy G. Murray, MD, MBA; Jerry A. Shields, M.D.
The Socioeconomics of Diabetic Retinopathy
By: Moneesh Patel, MBChB; Hean-Choon Chen, MBBS
Data from the United Kingdom quantify the societal burden of diabetic eye disease
Use of Membrane Blue in ILM and ERM Peeling
By: Brian C. Joondeph, MD, FACS
A retinal surgeon shares his experience with this new visualization agent
New Approaches to Retinal Laser Therapy
By: Seenu M. Hariprasad, M.D.; Michael D. Ober, MD
Lasers are an essential tool in treating retinal disease but still fall short of their full potential. We describe innovations we hope to see in the future.
Can Early Laser Therapy Delay Disease Progression?
By: John Marshall, PhD, FRCPATH, FRCOPHTH
The pioneer of short-pulse "Retina Regeneration Therapy" explains the theory and early results
By: Jason S. Slakter, M.D.
From the editor-in-chief
By: Jerry Helzner, Senior Editor; René Luthe, Senior Associate Editor
Alcon initiatives in retinal arena; At ASCs, a retinal reprieve; Dr. Ambati cautions on 21-NT siRNAs; and more
Clinical Trial Spotlight
By: Andrew E. Mathis, PhD, Medical Editor
New life for Macugen?
By: Riva Lee Asbell
Retina coding basics to help avoid audits
By: Leslie Goldberg, Associate Editor
MacuTrition: A Nutritional Supplement That Benefits DR Patients